Caseware UK (AP4) 2025.0.111 2025.0.111 true18false2024-09-01false22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09167956 2024-09-01 2025-08-31 09167956 2023-09-01 2024-08-31 09167956 2025-08-31 09167956 2024-08-31 09167956 c:Director1 2024-09-01 2025-08-31 09167956 c:Director2 2024-09-01 2025-08-31 09167956 d:Buildings 2024-09-01 2025-08-31 09167956 d:Buildings 2025-08-31 09167956 d:Buildings 2024-08-31 09167956 d:Buildings d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09167956 d:PlantMachinery 2024-09-01 2025-08-31 09167956 d:PlantMachinery 2025-08-31 09167956 d:PlantMachinery 2024-08-31 09167956 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09167956 d:MotorVehicles 2024-09-01 2025-08-31 09167956 d:MotorVehicles 2025-08-31 09167956 d:MotorVehicles 2024-08-31 09167956 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09167956 d:FurnitureFittings 2024-09-01 2025-08-31 09167956 d:FurnitureFittings 2025-08-31 09167956 d:FurnitureFittings 2024-08-31 09167956 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09167956 d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09167956 d:CurrentFinancialInstruments 2025-08-31 09167956 d:CurrentFinancialInstruments 2024-08-31 09167956 d:Non-currentFinancialInstruments 2025-08-31 09167956 d:Non-currentFinancialInstruments 2024-08-31 09167956 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 09167956 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 09167956 d:Non-currentFinancialInstruments d:AfterOneYear 2025-08-31 09167956 d:Non-currentFinancialInstruments d:AfterOneYear 2024-08-31 09167956 d:ShareCapital 2025-08-31 09167956 d:ShareCapital 2024-08-31 09167956 d:RetainedEarningsAccumulatedLosses 2025-08-31 09167956 d:RetainedEarningsAccumulatedLosses 2024-08-31 09167956 c:FRS102 2024-09-01 2025-08-31 09167956 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 09167956 c:FullAccounts 2024-09-01 2025-08-31 09167956 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 09167956 2 2024-09-01 2025-08-31 09167956 e:PoundSterling 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure
Registered number: 09167956













Virtue Health Limited

Financial statements
Information for filing with the registrar

31 August 2025




 
Virtue Health Limited


Balance sheet
At 31 August 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
758,185
789,970

  
758,185
789,970

Current assets
  

Stocks
  
15,377
19,362

Debtors
 5 
1,210,734
1,319,859

Cash at bank and in hand
  
177,905
147,413

  
1,404,016
1,486,634

Creditors: amounts falling due within one year
 6 
(900,998)
(719,171)

Net current assets
  
 
 
503,018
 
 
767,463

Total assets less current liabilities
  
1,261,203
1,557,433

Creditors: amounts falling due after more than one year
 7 
(349,997)
(407,784)

Provisions for liabilities
  

Deferred tax
  
(31,111)
(37,146)

Net assets
  
880,095
1,112,503


Capital and reserves
  

Called up share capital 
  
2
2

Profit and loss account
  
880,093
1,112,501

Shareholders' funds
  
880,095
1,112,503


1

 
Virtue Health Limited

    
Balance sheet (continued)
At 31 August 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 September 2026.




A Sood
N Patel
Director
Director

Registered number: 09167956

The notes on pages 3 to 8 form part of these financial statements. 

2

 
Virtue Health Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

1.


General information

Virtue Health Limited ('the company') is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is 2nd Floor Citygate, St James' Boulevard, Newcastle upon Tyne, NE1 4JE.

2.Accounting policies

 
2.1

Statement of compliance

The financial statements have been prepared in accordance with Section 1A of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) and the Companies Act 2006.

 
2.2

Revenue

The turnover recognised in the profit and loss account represents private fees income receivable during the year.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

3

 
Virtue Health Limited
 

 
Notes to the financial statements
Year ended 31 August 2025

2.Accounting policies (continued)

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Freehold property
-
2%
straight line
Plant and machinery
-
25%
reducing balance
Motor vehicles
-
25%
reducing balance
Fixtures and fittings
-
10%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

4

 
Virtue Health Limited
 

 
Notes to the financial statements
Year ended 31 August 2025

2.Accounting policies (continued)

 
2.8

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.9

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Deferred tax liabilities are also presented within provisions but are measured in accordance with the accounting policy on taxation.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.10

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

5

 
Virtue Health Limited
 

 
Notes to the financial statements
Year ended 31 August 2025

2.Accounting policies (continued)


2.10
Financial instruments (continued)

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the year was 18 (2024 - 22).


4.


Tangible fixed assets





Freehold property
Plant and machinery
Motor vehicles
Fixtures and fittings
Total

£
£
£
£
£



Cost


At 1 September 2024
651,199
298,072
66,680
45,884
1,061,835


Additions
-
7,975
-
-
7,975



At 31 August 2025

651,199
306,047
66,680
45,884
1,069,810



Depreciation


At 1 September 2024
19,894
230,917
2,096
18,958
271,865


Charge for the year
3,354
17,567
16,146
2,693
39,760



At 31 August 2025

23,248
248,484
18,242
21,651
311,625



Net book value



At 31 August 2025
627,951
57,563
48,438
24,233
758,185



At 31 August 2024
631,305
67,155
64,584
26,926
789,970

6

 
Virtue Health Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

5.


Debtors

2025
2024
£
£


Trade debtors
982
-

Other debtors
1,171,397
1,213,853

Prepayments and accrued income
38,355
106,006

1,210,734
1,319,859



6.


Creditors: amounts falling due within one year

2025
2024
£
£

Trade creditors
38,616
46,258

Other taxation and social security
54,868
16,098

Other creditors
22,257
9,300

Accruals and deferred income
543,745
457,642

Corporation tax
181,348
127,330

Bank loans
47,699
50,077

Obligations under finance lease and hire purchase contracts
12,465
12,466

900,998
719,171



7.


Creditors: amounts falling due after more than one year

2025
2024
£
£

Bank loans
313,588
358,910

Net obligations under finance leases and hire purchase contracts
36,409
48,874

349,997
407,784


7

 
Virtue Health Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

8.


Transactions with directors

During the year N Patel operated a loan account to record the amounts due to and from the company. 

The amounts advanced from the company to the director were £168,515. The amounts repaid from the director to the company were £193,788. At 31 August 2025 the balance due from the director was £532,388 (2024: £557,661 due from the director).

During the year A Sood operated a loan account to record the amounts due to and from the company. 

The amounts advanced from the company to the director were £175,124. The amounts repaid from the director to the company were £192,000. At 31 August 2025 the balance due from the director was £555,823 (2024: £572,699 due from the director).

 
8